General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer

Area of Science:

• Molecular Biology
• RNA Splicing
• Gene Regulation

Background:

• Pre-mRNA splicing is a critical process in gene expression.
• General splicing factors play crucial roles in regulating splicing efficiency.
• Alternative pre-mRNA processing allows for the production of multiple protein isoforms from a single gene.

Purpose of the Study:

• To investigate the role of the general splicing factor SF2/ASF in the splicing of bovine growth hormone (bGH) pre-mRNA.
• To determine the binding specificity of SF2/ASF to exonic splicing enhancers (ESEs).
• To elucidate the mechanism by which SF2/ASF influences bGH intron D splicing and its interaction with other splicing factors.

Main Methods:

• In vitro splicing assays using bGH pre-mRNA.
• Electrophoretic mobility shift assays (EMSAs) to study protein-RNA interactions.
• Analysis of the effects of splicing factors SF2/ASF, SC35, and hnRNP A1 on intron D splicing.

Main Results:

• SF2/ASF binds sequence-specifically to a purine-rich ESE in the last exon of bGH pre-mRNA.
• SF2/ASF significantly stimulates the in vitro splicing of bGH intron D.
• SC35 does not bind the ESE and has no effect on bGH intron D splicing.
• hnRNP A1 counteracts the splicing-stimulatory effect of SF2/ASF on bGH intron D.

Conclusions:

• SF2/ASF recognizes ESE sequences, suggesting a role in both alternative and constitutive pre-mRNA splicing.
• The balance between SF2/ASF and hnRNP A1 levels is critical for regulating bGH intron D splicing efficiency.
• These interactions may represent a key mechanism for alternative pre-mRNA processing in vivo.